Avoro Capital Advisors LLC

Holdings History for Tourmaline Bio, Inc. - Common stock, par value $0.0001 per share (TRML)

Symbol: TRML
Investment type: Equity / Common stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 2,555,555 shares
Security Ownership %: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

Avoro Capital Advisors LLC ownership in Tourmaline Bio, Inc. Common stock, par value $0.0001 per share (TRML)

14 Aug 2025 - Avoro Capital Advisors LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,555,555 shares of Tourmaline Bio, Inc. Common stock, par value $0.0001 per share (TRML). This represents 10% ownership of the company. This is the first filing by Avoro Capital Advisors LLC disclosing ownership of Tourmaline Bio, Inc. Common stock, par value $0.0001 per share (TRML).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Avoro Capital Advisors LLC	10%		$41,374,435	2,555,555			$16.19	13G/A	30 Jun 2025	14 Aug 2025, 07:04

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-1.6%	$0	0	-2,555,555	-100%	$47.98	Q4 2025
30 Sep 2025	1.6%	0%	$122,232,196	2,555,555	0		$47.83	Q3 2025
30 Jun 2025	0.72%	+0.04%	$40,863,324	2,555,555	+130,555	+5.4%	$15.99	Q2 2025
31 Mar 2025	0.58%	+0.05%	$36,884,250	2,425,000	+202,778		$15.21	Q1 2025
31 Dec 2024	0.64%	0%	$45,066,662	2,222,222	0		$20.28	Q4 2024
30 Sep 2024	0.83%	0%	$57,133,328	2,222,222	0		$25.71	Q3 2024
30 Jun 2024	0.38%	0%	$28,577,775	2,222,222	0		$12.86	Q2 2024
31 Mar 2024	0.59%	+0.36%	$50,888,884	2,222,222	+1,353,815	+156%	$22.90	Q1 2024
31 Dec 2023	0.31%	+0.31%	$22,734,895	868,407	+868,407	NEW	$26.18	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.